
Endocrinologist & Clinical Prof. @ NYU | Co-Host @EndoJournalClub | #EndoTwitter | #HealthyLiving | Evidence-Based Medicine | Mom x GF kids | Tweets mine
New York City
Joined January 2011
- Tweets1.9K
- Following1.7K
- Followers3K
- Likes5.8K
Super excited our ‘Update on Endocrine Disorders During Pregnancy’ is officially published 📘- incredible collab with endocrine gurus @MariaPapaleont1 @nyuendocrine @NYUGSOM_DGIMCI @ElsevierConnect #EndoTwitter #Pregnancy @TheEndoSociety @TheAACE @AmThyroidAssn
So great to chat about everything #hormone related. Thanks for the invitation @MarkPochapin @NYUDocs
We couldn’t “rebrand” #PCOS without an all-star team of #hormone experts! A special thanks to @DrPess, @doctorjny, & Dr. Gillian Goddard for joining our @nyulangone #endocrinology roundtable discussion w/@MarkPochapin!
#WomensHealth @SIRIUSXM #HealthTalk #PCOSAwareness
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
Dr. Rachel Pessah-Pollack @DrPess breaks down supplement stacking social media trend and if it actually helps your health cbsnews.com/video/doctor-bre…
Thanks for having me. Such a pleasure to discuss the risks of overlapping supplements.
“If you’re not treating a deficiency, you could potentially develop a toxicity”: A growing social media trend called “supplement stacking” could see users taking in the same vitamins multiple times a day — and that could potentially lead to health complications, Dr. Rachel Pessah-Pollack (@DrPess) explains.
1
3
138
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
A Mayo Clinic-developed artificial intelligence (AI) model can help specialists detect pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis. It identifies subtle signs of disease before tumors are visible, when curative treatment may still be possible. The findings, published in Gut, mark a milestone in Mayo Clinic's multiyear research effort to enable earlier detection of one of the deadliest cancers.
Learn more: mayocl.in/4eippBP
Sports Medicine is LIVE. Drs. Dennis Cardone & Daniel Kaplan are talking with @AliyaFeroeMD about orthopedic care in #TGD patients & exercise for those with #osteoporisis with @DrPess. 877-698-3627 sxm.app.link/DoctorRadio
4
260
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
Non-English language preference linked to significantly lower #CGM prescription rates in #T2D, even among high-risk insulin users (7.6–7.8% gaps) — independent of clinical factors. Those who could benefit most may be missing out. bit.ly/4nqvnCX @DrPess @JAMANetworkOpen
Choice of #GLP1 matters
Tirzepatide in a target emulation trial demonstrates significantly lower MACE (HR 0.8) and all cause mortality (HR 0.6) compared to dulaglutide in T2DM. 🤯
#ADASciSessions #ADA2025
207
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
Tirzepatide in a target emulation trial demonstrates significantly lower MACE (HR 0.8) and all cause mortality (HR 0.6) compared to dulaglutide in T2DM. 🤯
#ADASciSessions #ADA2025
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
The oral non-peptide GLP-1 agonist space is quickly filling up
#ADA2025 #ADASciScessions
Thanks for featuring me in this article. Beyond crucial we prioritize #bone loss prevention! #Health #osteoporosis @GoHealio
📢“You want these patients to be as mobile as possible,” said @DrPess from @UW.
Read more about #osteoporosis in #rheumatoidarthritis @HealioRheum 👇
healio.com/news/rheumatology…
4
288
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
📢“You want these patients to be as mobile as possible,” said @DrPess from @UW.
Read more about #osteoporosis in #rheumatoidarthritis @HealioRheum 👇
healio.com/news/rheumatology…
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
Replying to @ENirenberg
This is a wild story that anyone interested in or supplementing vitamin D should read — thank you very much for sharing it. @DrNadolsky @DrKarlNadolsky had a nice pod on the topic last summer w @DrPess podcasts.apple.com/us/podcas…
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
Switching to #tirzepatide was superior to increasing to dulaglutide 4.5mg a week for both A1c and weight loss:
acpjournals.org/doi/10.7326/…
@AnnalsofIM
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
In those taking tirzepatide in SURMOUNT-1, of the weight lost approximately 75% was fat mass and 25% was lean mass.
This degree of lean mass loss is consistent with other medications.
Tirzepatide was not associated with a proportionally greater loss of lean tissue in older adults, who are at higher risk for frailty/sarcopenia.
Changes in body composition following tirzepatide treatment in a substudy of participants from the SURMOUNT-1 trial; the change in body weight, fat mass and lean mass from baseline to Week 72 was −21.3%, −33.9% and −10.9%, consistent across subgroups dom-pubs.onlinelibrary.wiley…
So honored to receive this promotion. Grateful to my incredible mentors who helped me on this journey. @nyuendocrine @NYULH_DeptofMed
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
January is #ThyroidAwarenessMonth! 🦋 Dr. Rachel Pessah-Pollack, MD, FACE, shares why thyroid health matters year-round. Let’s raise awareness and support those living with thyroid conditions!
Head over to our LinkedIn to see the full quote from @DrPess: shorturl.at/TkSJg
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
There is no shame in taking a medicine for your weight just like there is no shame in taking a medicine for your high blood pressure or depression.
Rachel Pessah-Pollack, M.D., F.A.C.E. retweeted
Amazing talk! Loved hearing about all the thyroid history that got us where we are today. #2024ATA @AngelaLeung9
Fantastic Sawin lecture by @AngelaLeung9 on the landmark discoveries in maternal-fetal #thyroid disease over the last century at #2024ATA 👩🍼🦋
#Hypothyroidism #Pregnancy #Hyperthyroidism #Endocrinology
Favorite part of #2024ATA
- catching up with friends across the 🌎#2024ATA #thyroid @AngelaLeung9 @MariaPapaleont1





























